Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Motor Activity 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma 11Lymphoma, Follicular 5Leukemia 5Leukemia, Lymphocytic, Chronic, B-Cell 4Breast Neoplasms 4Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Obesity 2Neoplasms 2Hodgkin Disease 2Fatigue 2Cardiotoxicity 2Waldenstrom Macroglobulinemia 1Ventricular Dysfunction, Left 1Urogenital Neoplasms 1Thyroid Neoplasms 1Sarcopenia 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Parasomnias 1Overweight 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1

Interventions

ficlatuzumab 1Vorinostat 1Vascular Stiffness 1Sugars 1Pulse Wave Analysis 1Physical Conditioning, Human 1Exercise 1Erlotinib Hydrochloride 1Electrocardiography 1Echocardiography 1Bortezomib 1Blood Specimen Collection 1Blood Pressure 1Atorvastatin 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Exercise × Lymphoid × Clear all
NCT06270667 2024-03-22

LYMfit

Norwegian School of Sport Sciences

Phase NA Recruiting
280 enrolled
Lymphoid

Cardiovascular Diseases, Lymphoma, Motor Activity, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡